Kimberley Lee, MD, MHS
Kimberley Lee, MD, MHS
Specialty: Medical Oncology
Program: Breast Oncology
Dr. Kimberley Lee is an Assistant Member in the Department of Breast Oncology. Dr. Lee received her MD from Johns Hopkins University, School of Medicine and her MHS in General Epidemiology from Johns Hopkins University, Bloomberg School of Public Health in Baltimore, Maryland. She completed an Internal Medicine Residency at Johns Hopkins Bayview Medical Center. Most recently she completed a Medical Oncology Fellowship at Johns Hopkins Sidney Kimmel Cancer Center. Dr. Lee’s research expertise involves using the tools of epidemiology, health services research, and implementation science to investigate modifiable biological, clinical, and health care related factors that contribute to disparities in breast cancer survival. She is particularly interested in developing interventions to address these factors and improve survival for women with breast cancer. She has experience in the analysis of large databases to better understand disparities in care and performs qualitative work to understand patient and provider factors that impact breast cancer care.
Education & Training
- Johns Hopkins Sidney Kimmel Cancer Center - Medical Oncology
- Johns Hopkins Bayview Medical Center - General Internal Medicine
- Johns Hopkins University, School of Medicine - MD
Clinical Trial 22157
A Mixed-Methods Study to Inform the Use of Patient Education and Digital Technology to Increase the Racial/Ethnic Diversity of Clinical Trial Participants
Clinical Trial 22572
Understanding racial differences and disparities in ovarian function suppression decision making and initiation among young women with breast cancer
Clinical Trial 22690
Emshape Engaging Mobile Health for Symptom Monitoring and Health Promotion for Black Women on Endocrine Therapy for Breast Cancer.
Clinical Trial 23056
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone to Improve Persistence with Endocrine Therapy in Young Women with Stage I-III Breast Cancer (Aspen)
- Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Cui ZL, Lee KT. A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer. Future Oncol. 2022 Jul.18(21):2667-2682. Pubmedid: 35611679.
- Norman H, Lee KT, Stearns V, Alcorn SR, Mangini NS. Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature. Clin Breast Cancer. 2022 Jan.22(1):e65-e73. Pubmedid: 34419350. Pmcid: PMC8916093.
- Lee KT, Zale AD, Ibe CA, Johnston FM. Patient Navigator and Community Health Worker Attitudes Toward End-of-Life Care. J Palliat Med. 2021 Nov.24(11):1714-1720. Pubmedid: 34403597. Pmcid: PMC8823672.
- Lee KT, George M, Lowry S, Ashing KT. A Review and Considerations on Palliative Care Improvements for African Americans With Cancer. Am J Hosp Palliat Care. 2021 Jun.38(6):671-677. Pubmedid: 32489113.
- Lee K, Gani F, Canner JK, Johnston FM. Racial Disparities in Utilization of Palliative Care Among Patients Admitted With Advanced Solid Organ Malignancies. Am J Hosp Palliat Care. 2021 Jun.38(6):539-546. Pubmedid: 32372699. Pmcid: PMC8787808.
- Lee KT, Jacobs L, Walsh EM, Stearns V, Segal JB. Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer. Breast Cancer Res Treat. 2020 Sep.184(3):965-975. Pubmedid: 32914353. Pmcid: PMC7658028.
- Kubi B, Istl AC, Lee KT, Conca-Cheng A, Johnston FM. Advance Care Planning in Cancer: Patient Preferences for Personnel and Timing. JCO Oncol Pract. 2020 Sep.16(9):e875-e883. Pubmedid: 32282265.
- Kubi B, Enumah ZO, Lee KT, Freund KM, Smith TJ, Cooper LA, Owczarzak JT, Johnston FM. Theory-Based Development of an Implementation Intervention Using Community Health Workers to Increase Palliative Care Use. J Pain Symptom Manag. 2020 Jul.60(1):10-19. Pubmedid: 32092401. Pmcid: PMC8787809.
- Dean LT, George M, Lee KT, Ashing K. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence. Cancer. 2020 Aug.126(16):3606-3612. Pubmedid: 32438466. Pmcid: PMC7467097.
- Wolff JL, Aufill J, Echavarria D, Heughan JA, Lee KT, Connolly RM, Fetting JH, Jelovac D, Papathakis K, Riley C, Stearns V, Thorner E, Zafman N, Levy HP, Dy SM, Wolff AC. Sharing in care: engaging care partners in the care and communication of breast cancer patients. Breast Cancer Res Treat. 2019 Aug.177(1):127-136. Pubmedid: 31165374. Pmcid: PMC6640103.
- Lee KT, Harris RP, Schoenborn NL. Individualized Approach to Cancer Screening in Older Adults. Clin Geriatr Med. 2018 Feb.34(1):11-23. Pubmedid: 29129211.
- Schoenborn NL, Lee K, Pollack CE, Armacost K, Dy SM, Bridges JFP, Xue QL, Wolff AC, Boyd C. Older Adults' Views and Communication Preferences About Cancer Screening Cessation. JAMA Intern Med. 2017 Aug.177(8):1121-1128. Pubmedid: 28604917. Pmcid: PMC5564296.
- Schoenborn NL, Lee K, Pollack CE, Armacost K, Dy SM, Xue QL, Wolff AC, Boyd C. Older Adults' Preferences for When and How to Discuss Life Expectancy in Primary Care. J Am Board Fam Med. 2017 Aug.30(6):813-815. Pubmedid: 29180556. Pmcid: PMC5751432.
- Lee K, Shah NP, Christenson ES, Zakaria S, Okwuosa I. Acute decompensated heart failure as the initial presentation of isolated aortitis. Future Cardiol. 2016 Jul.12(4):467-470. Pubmedid: 27291815.
- Lee K, Wright SM, Wolfe L. The clinically excellent primary care physician: examples from the published literature. BMC Fam Pract. 2016 Dec.17(1):169. Pubmedid: 27964709. Pmcid: PMC5153856.
- Lee KT, Abadir PM. Failure of Glucose Monitoring in an Individual with Pseudohypoglycemia. J Am Geriatr Soc. 2015 Aug.63(8):1706-1708. Pubmedid: 26289697. Pmcid: PMC5407681.
GrantsTitle: Developing a Culturally Tailored mHealth Symptom Monitoring Intervention to Improve Adherence to Endocrine Therapy Among Black Women with Breast Cancer
Sponsor: Nat Institutes of Health
PI: Lee, K.
Title: A Mixed-Methods Study to Develop a Culturally-Tailored Multi-Level Intervention to Increase the Racial/Ethnic Diversity of Clinical Trial Participants
Sponsor: V Fdtn for Cancer Research
PI: Soliman, H., CO-PI: Lee, K.
Title: Understanding racial differences and disparities in OFS decision making and initiation among young women with breast cancer
PI: Lee, K.
Patient CommentsOverall Satisfaction4.5
84 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.Learn more about our patient satisfaction survey
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
- The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
- He or she may be a researcher or other type of provider that does not see patients.
- The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.